CTRI/2022/07/043782尚未招募未知
To evaluate Ophthalmological safety of test product involving subjects of normal eye conditions on healthy female subjects.
ONESTO LABS PVT LTD0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Indian Female subjects
- •2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
- •3.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarâ?¦.)
- •4.Having normal eye conditions
- •5.Having habit of using under eye cream
排除标准
- •6.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
- •7.Having refused to give his/her assent by not signing the consent form
- •8.Taking part in another study liable to interfere with this study
- •9.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)
- •10.Having a progressive asthma (either under treatment or last fit in the last 2 years)
- •11.Being epileptic.
- •12.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
- •13.Having cutaneous hypersensitivity
- •14.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
- •15.Following a chronic medicinal treatment comprising any of the following products: aspirin based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
- •16.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
- •17.Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit
- •18.Having applied a cosmetic product (included make-up) or skin care product on the studied areas the first day of the study (only face cleaned with water is accepted)
- •19.Refusing to follow the restrictions below during the study: Do not take part in any family planning activities leading to pregnancy and breastfeeding Do not take part in another study liable to interfere with this study Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). Mascot Spincontrol 10 / 21 Product A XXX-6Y01-DD-JE22-XXX-PR (V01) Reference of the specification SPE-CNL-PM02-Main Part of Protocol-02-I This document is the property of Mascot Spincontrol. D:QASTUDY DOCUMENTSXXX-6Y01-DD-JE22XXX-6Y01-DD-JE22-XXX- PR (V01) 2022 06 18.docx Do not change cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit. During the study: Do not use other eye related and/ or eye make up than the tested products to the studied areas. The day of the measurements: No test product or any other eye make up must be used
- •20.Having applied make-up products on eyes in the 48 hours preceding the start of the study.
- •21.Having permanent make-up on the studied area.
- •22.Having ocular problems (stye, chalazion, conjunctivitis).
- •23.Having applied an eye product and/or make up for eye, to the studied area the day of the measurements.
- •24.Do not itch the eyes
- •25.Do not use any eye drops or any eye treatment/ surgery during the study
研究者
相似试验
已完成
Unknown
Safety checking of Product on eyesCTRI/2023/03/050979DPKA UNIVERSAL CONSUMER VENTURES PRIVATE LIMITED33
尚未招募
Unknown
Assessment of Ophthalmological safety of skin care productCTRI/2023/11/059530DPKA UNIVERSAL CONSUMER VENTURES PRIVATE LIMITED
已完成
Unknown
To test the safety of hydration mist on eyes during usage.CTRI/2023/05/053058DPKA Universal Consumer Ventures Private Limited33
已完成
4 期
To evaluate the safety of Primary Irritation Patch Test test product in healthy volunteersCTRI/2022/12/048219Vasu Health Care24
已完成
4 期
Safety evaluation of test products on healthy skin typeCTRI/2023/03/050796Dabur India Limited24